This session explores a paradigm shift towards collaboration between manufacturers and payers, fostering win-win solutions that improve patient access and generate cost savings for the healthcare system.

• Define common objectives for both manufacturers and payers, focusing on patient adherence, improved health outcomes and cost-effectiveness
• Develop copay programs that align with value-based care initiatives
• Discuss strategies for secure data exchange between manufacturers and payers to demonstrate program effectiveness and optimize resource allocation
• Examine current and emerging regulations impacting copay reimbursement and explore collaborative approaches to ensure program compliance
• Develop strategies to foster trust and build long-term partnerships between manufacturers and payers to create a sustainable copay reimbursement ecosystem

• Examine therapeutic areas, once dominated by a single player, that are now experiencing increased competition and analyze the impact on rebate negotiation and market share
• Explore the considerations influencing formulary placement for existing therapies in the face of emerging competitive alternatives
• Uncover how pharmaceutical companies are strategizing to defend their market share in the face of increased competition

This session will offer an overview of the Affordability industry issues, trends and news to help attendees catch up on the most important developments:

• The Market: Current affordability landscape, including higher patient OOP costs, reduced HCP accessibility, expanded payer utilization tactics, etc.
• Hot Topics: Get a grip on today’s copay news headlines such as accumulators, maximizers, alternative funding programs, etc.
• Sleepless Nights: Grab new insight on the latest legislation and regulation like the IRA, DOJ enforcement, compliance issues, etc.

• Benchmark with colleagues on the guardrails that need to be put in place and the processes that need to be updated to catch specialty carve outs
• Understand how the maximizer landscape is changing and the possibility of getting rid of accumulators
• Navigate the varying state laws within the copay ecosystem, including how to mitigate risk within your copay program in a way that is sustainable

• Uncover how integrated PSPs create holistic patient and provider support
• Understand best practices in streamlining patient services to decrease time to initiate therapy and overall turnaround times
• Learn how integration can allow better visibility to program data
• Discover how to enable reduction in overall hard and soft costs

As the regulatory landscape continues to evolve, many manufacturers are being forced to rethink their approach to copay.

• Uncover best practices in identifying and dealing with maximizers to lead a dynamic and sustainable copay program
• Understand the fine balance between patient prioritization and minimizing gross-to-net
• Learn strategies to design your copay program in an integrated fashion to improve efficiency and functionality
• Discuss the use of free trial and complimentary programs

During this session, unpack the Inflation Reduction Act and their respective implications on patient services.

• Uncover the nuances, unintended consequences and behavior economics of the IRA changes
• Better understand the smoothing enrollment process
• Discuss the impact on Medicare Part D patients

• Explore various methods beyond traditional approaches for forecasting gross-to-net
• Establish effective oversight mechanisms for program performance
• Emphasize the need for a comprehensive perspective on all copay ecosystem discounts
• Asses the effectiveness and tipping points of strategies such as rebating the PBM and offsetting patient copay
• Gain actionable insights into maximizing the efficiency of copay programs